​

Xencor (XNCR) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

XNCR Stock Forecast

Xencor (XNCR) stock forecast, based on 6 Wall Street analysts, predicts a 12-month average price target of $30.00, with a high of $30.00 and a low of $30.00. This represents a 59.32% increase from the last price of $18.83.

$15 $18 $21 $24 $27 $30 High: $30 Avg: $30 Low: $30 Last Closed Price: $18.83

XNCR Stock Rating

Xencor stock's rating consensus is Buy, based on 6 Wall Street analysts. The breakdown includes 1 Strong Buy (16.67%), 5 Buy (83.33%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 6 0 5 1 Strong Sell Sell Hold Buy Strong Buy

XNCR Forecast vs Benchmarks

TypeNameUpside
StockXencor59.32%
SectorHealthcare Stocks 25.20%
IndustryBiotech Stocks 63.35%

Price Target Trends

1M3M12M
# Anlaysts-14
Avg Price Target-$30.00$32.75
Last Closing Price$18.83$18.83$18.83
Upside/Downside-59.32%73.92%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jan, 2547--112
Dec, 24471-113
Nov, 24371-112
Oct, 244711114
Sep, 244711114
Latest Price Target by Analysts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Dec 02, 2024Edward TenthoffPiper Sandler$30.00$25.6017.19%59.32%
Jun 14, 2024Etzer DaroutBMO Capital$32.00$20.9053.11%69.94%
Jun 14, 2024Gregory RenzaRBC Capital$31.00$20.9947.69%64.63%
Apr 16, 2024Kaveri PohlmanBTIG$38.00$20.1188.96%101.81%
Oct 04, 2021Charles ZhuGuggenheim$54.00$35.5252.03%186.78%
May 05, 2021Dane LeoneRaymond James$58.00$40.7642.30%208.02%
Latest Upgrade/Downgrade by Analysts
DateCompanyPrevious RatingNew RatingRating Change
Sep 26, 2024RBC CapitalOutperformOutperformhold
Jun 14, 2024BMO CapitalOutperformOutperformhold
Jun 14, 2024RBC CapitalOutperformOutperformhold
May 10, 2024WedbushBuyBuyhold
Apr 16, 2024WedbushBuyBuyhold
Apr 16, 2024BTIGBuyBuyhold
Feb 28, 2024WedbushBuyBuyhold
Dec 06, 2022Cowen & Co.Outperforminitialise
Oct 13, 2022Raymond JamesStrong Buyupgrade

Financial Forecast

EPS Forecast

$-7 $-6 $-5 $-4 $-3 $-2 $-1 $0 $1 $2 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-1.11$1.42$-0.93$-2.08-----
Avg Forecast$-1.41$0.24$-1.51$-1.90$-3.66$-3.10$-2.75$-1.58$-2.35
High Forecast$-3.51$0.05$-3.94$-4.56$-3.94$-3.69$-3.70$-2.47$-6.98
Low Forecast$-0.30$0.61$-0.31$0.70$-3.44$-2.79$0.92$0.04$-0.18
Surprise %-21.28%491.67%-38.41%9.47%-----

Revenue Forecast

$0 $120M $240M $360M $480M $600M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$122.69M$275.11M$164.58M$168.34M-----
Avg Forecast$110.09M$194.55M$164.55M$197.61M$61.23M$113.93M$163.51M$221.98M$236.72M
High Forecast$43.27M$76.47M$63.59M$106.64M$48.42M$48.25M$163.40M$217.69M$68.43M
Low Forecast$236.52M$417.96M$368.50M$296.26M$68.72M$178.34M$163.63M$226.27M$594.59M
Surprise %11.44%41.41%0.02%-14.81%-----

Net Income Forecast

$-500M $-100M $300M $700M $1B $2B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-63.54M$82.63M$-55.18M$-126.09M-----
Avg Forecast$-52.28M$1.05B$1.09B$-126.09M$-223.35M$-204.45M$-190.12M$-73.71M$-142.42M
High Forecast$-62.74M$820.13M$851.78M$-153.74M$-238.40M$-223.23M$-224.00M$-149.61M$-422.34M
Low Forecast$-41.83M$1.27B$1.32B$-98.43M$-208.30M$-168.59M$55.53M$2.19M$-10.80M
Surprise %21.53%-92.10%-105.08%------

XNCR Forecast FAQ

Is Xencor stock a buy?

Xencor stock has a consensus rating of Buy, based on 6 Wall Street analysts. The rating breakdown includes 1 Strong Buy, 5 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Xencor is a favorable investment for most analysts.

What is Xencor's price target?

Xencor's price target, set by 6 Wall Street analysts, averages $30 over the next 12 months. The price target range spans from $30 at the low end to $30 at the high end, suggesting a potential 59.32% change from the previous close price of $18.83.

How does Xencor stock forecast compare to the average forecast of its sector, industry, and investment themes?

Xencor stock forecast shows a 59.32% upside, outperforming the average forecast for the healthcare stocks sector (25.20%) and underperforming the biotech stocks industry (63.35%).

What is the breakdown of analyst ratings for Xencor over the past three months?

  • January 2025: 33.33% Strong Buy, 58.33% Buy, 0% Hold, 0% Sell, 8.33% Strong Sell.
  • December 2024: 30.77% Strong Buy, 53.85% Buy, 7.69% Hold, 0% Sell, 7.69% Strong Sell.
  • November 2024: 25.00% Strong Buy, 58.33% Buy, 8.33% Hold, 0% Sell, 8.33% Strong Sell.

What is Xencor’s EPS forecast?

Xencor's average annual EPS forecast for its fiscal year ending in December is -3.66 for 2024, a 75.96% increase from the reported $-2.08 in 2023. The prediction for 2025 is $-3.1, $-2.75 for 2026, $-1.58 for 2027, and $-2.35 for 2028.

What is Xencor’s revenue forecast?

Xencor's average annual revenue forecast for its fiscal year ending in December is $61.23M for 2024, a -63.62% decrease from the reported $168.34M in 2023. The forecast for 2025 is $113.93M, $163.51M for 2026, $221.98M for 2027, and $236.72M for 2028.

What is Xencor’s net income forecast?

For its fiscal year ending in December, Xencor's average annual net income forecast is $-223M for 2024, reflecting an 77.14% increase from the reported $-126M in 2023. The projection for 2025 is $-204M, $-190M for 2026, $-73.713M for 2027, and $-142M for 2028.